SERPINH1 and osteogenesis imperfecta: Moreover, photoactivatable Hsp47 might inspire new therapeutic concepts for treating collagen‐related defects like osteogenesis imperfecta, Ehlers–Danlos syndrome, and epidermolysis bullosa by promoting correct folding of collagen.